Montelukast Prescribing at RISE PARK SURGERY
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
460
Total Quantity
18.0K
NHS Cost
£959
vs National Avg
-32.8%
RISE PARK SURGERY prescribed 460 items of Montelukast over the last 12 months at a cost of £959 to the NHS. This is 32.8% below the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
40
Jul 2026
31
Jul 2026
41
Jul 2026
34
Jul 2026
44
Jul 2026
32
Jul 2026
40
Jul 2026
42
Jul 2026
42
Jul 2026
40
Jul 2026
35
Jul 2026
39
Prescribing Details
| Total Items | 460 |
|---|---|
| Total Quantity | 18,009 |
| Total NHS Cost | £959 |
| Presentations | 4 different forms |
| vs National Average | -32.8% |
Montelukast Prescribing Comparison
| This practice | 460 items |
|---|---|
| National average per practice | 685 items |
| Difference | -32.8% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.